Impact of Histology on Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Advanced or Metastatic Urothelial Carcinoma in the Phase 3 KEYNOTE-045 and KEYNOTE-361 Trials
Impact of Histology on Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Advanced or Metastatic Urothelial Carcinoma in the Phase 3 KEYNOTE-045 and KEYNOTE-361 Trials
José Ángel Arranz, Abhishek Bavle, Eli Rosenbaum, Sun Young Rha et al.
Citations
1 citations
Journal
Clinical Genitourinary Cancer
Topics
Bladder and Urothelial Cancer Treatments
Field-Weighted Citation Impact (FWCI)
0.57
article
Impact of Histology on Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Advanced or Metastatic Urothelial Carcinoma in the Phase 3 KEYNOTE-045 and KEYNOTE-361 Trials
José Ángel Arranz, Abhishek Bavle, Eli Rosenbaum, Sun Young Rha, David Sarid, Ying‐Chun Shen, José Muñoz-Langa, Jean‐Pascal Machiels, Naoto Sassa, Bhumsuk Keam, Maureen J.B. Aarts, Blanca Homet Moreno, Yasuhisa Fujii, Patrizia Giannatempo, Stéphane Culine, Jing Xu, Wen-Pin Su, Fabio Calabrò
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Clinical Genitourinary CancerVol. 23(2)
Institutions
Merck & Co., Inc., Rahway, NJ, USA (United States) (US), Cliniques Universitaires Saint-Luc (BE), Aichi Medical University (JP), Université Paris Cité (FR), Tel Aviv Sourasky Medical Center (IL), Maastricht University Medical Centre (NL), Rabin Medical Center (IL), Seoul National University Hospital (KR), Hospital General Universitario Gregorio Marañón (ES), Hospital Universitari i Politècnic La Fe (ES), Assistance Publique – Hôpitaux de Paris (FR), National Taiwan University Hospital (TW), Hôpital Saint-Louis (FR), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), National Cheng Kung University Hospital (TW), Yonsei University Health System (KR)
Funders
Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Gilead Sciences, Handok, Merck KGaA, Taiho Pharmaceutical, Les Laboratories Pierre Fabre, BeiGene, Incyte, MacroGenics, Seagen, Eisai, Astellas Pharma, Ono Pharmaceutical, Ipsen, Daiichi Sankyo Europe